Mark E. Hensley - Chief Operating Officer at HERON THERAPEUTICS, INC. /DE/

Issuer-level insider activity

Role
Chief Operating Officer
Issuer ticker
HRTX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Mark E. Hensley since 21 Oct 2025

Reported holdings for Mark E. Hensley in HERON THERAPEUTICS, INC. /DE/

Form 4 holding Chief Operating Officer

HERON THERAPEUTICS, INC. /DE/

Security class
Employee Performance Stock Option (Right to Buy)
Shares / value
900,000
Estimated value
$1,980,000
Report date
28 Apr 2025
Price
$2.20
Ownership
Direct
Underlying class
Common Stock
Underlying amount
900,000
Form 4 holding Chief Operating Officer

HERON THERAPEUTICS, INC. /DE/

Security class
Employee Stock Option (Right to Buy)
Shares / value
500,000
Estimated value
$1,100,000
Report date
28 Apr 2025
Price
$2.20
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500,000

Transaction history for Mark E. Hensley in HERON THERAPEUTICS, INC. /DE/

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .